Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

USA - NYSE:AMRC - US02361E1082 - Common Stock

41.54 USD
-0.17 (-0.41%)
Last: 10/14/2025, 8:04:00 PM
41.54 USD
0 (0%)
After Hours: 10/14/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, AMRC scores 3 out of 10 in our fundamental rating. AMRC was compared to 54 industry peers in the Construction & Engineering industry. AMRC has a bad profitability rating. Also its financial health evaluation is rather negative. AMRC is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AMRC had positive earnings in the past year.
AMRC had a negative operating cash flow in the past year.
In the past 5 years AMRC has always been profitable.
AMRC had negative operating cash flow in 4 of the past 5 years.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AMRC has a Return On Assets of 1.44%. This is comparable to the rest of the industry: AMRC outperforms 40.74% of its industry peers.
Looking at the Return On Equity, with a value of 5.99%, AMRC is in line with its industry, outperforming 44.44% of the companies in the same industry.
The Return On Invested Capital of AMRC (2.16%) is worse than 64.81% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AMRC is significantly below the industry average of 17.10%.
Industry RankSector Rank
ROA 1.44%
ROE 5.99%
ROIC 2.16%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AMRC's Profit Margin of 3.33% is in line compared to the rest of the industry. AMRC outperforms 53.70% of its industry peers.
In the last couple of years the Profit Margin of AMRC has declined.
Looking at the Operating Margin, with a value of 5.11%, AMRC is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AMRC has declined.
AMRC has a Gross Margin (14.48%) which is in line with its industry peers.
AMRC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.11%
PM (TTM) 3.33%
GM 14.48%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMRC is destroying value.
Compared to 1 year ago, AMRC has more shares outstanding
The number of shares outstanding for AMRC has been increased compared to 5 years ago.
Compared to 1 year ago, AMRC has an improved debt to assets ratio.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.25, we must say that AMRC is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.25, AMRC is doing worse than 72.22% of the companies in the same industry.
A Debt/Equity ratio of 1.61 is on the high side and indicates that AMRC has dependencies on debt financing.
AMRC has a worse Debt to Equity ratio (1.61) than 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 1.25
ROIC/WACC0.19
WACC11.29%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 1.56 indicates that AMRC should not have too much problems paying its short term obligations.
The Current ratio of AMRC (1.56) is better than 72.22% of its industry peers.
A Quick Ratio of 1.54 indicates that AMRC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.54, AMRC is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.54
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.33% over the past year.
The Earnings Per Share has been growing slightly by 3.47% on average over the past years.
Looking at the last year, AMRC shows a very strong growth in Revenue. The Revenue has grown by 22.86%.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)8.33%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%166.67%
Revenue 1Y (TTM)22.86%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%7.83%

3.2 Future

AMRC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.21% yearly.
Based on estimates for the next years, AMRC will show a quite strong growth in Revenue. The Revenue will grow by 8.88% on average per year.
EPS Next Y-24.12%
EPS Next 2Y4.45%
EPS Next 3Y16.47%
EPS Next 5Y20.21%
Revenue Next Year8.53%
Revenue Next 2Y8.81%
Revenue Next 3Y9.6%
Revenue Next 5Y8.88%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 35.50, the valuation of AMRC can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as AMRC.
The average S&P500 Price/Earnings ratio is at 27.50. AMRC is valued slightly more expensive when compared to this.
A Price/Forward Earnings ratio of 37.33 indicates a quite expensive valuation of AMRC.
AMRC's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.99. AMRC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 35.5
Fwd PE 37.33
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AMRC's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.29
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

AMRC's earnings are expected to grow with 16.47% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)10.23
EPS Next 2Y4.45%
EPS Next 3Y16.47%

0

5. Dividend

5.1 Amount

No dividends for AMRC!.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (10/14/2025, 8:04:00 PM)

After market: 41.54 0 (0%)

41.54

-0.17 (-0.41%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners101.64%
Inst Owner Change0.1%
Ins Owners7.71%
Ins Owner Change2.5%
Market Cap2.19B
Analysts81.18
Price Target34.91 (-15.96%)
Short Float %9.54%
Short Ratio4.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)609.63%
Min EPS beat(2)64.35%
Max EPS beat(2)1154.9%
EPS beat(4)2
Avg EPS beat(4)294.8%
Min EPS beat(4)-31.77%
Max EPS beat(4)1154.9%
EPS beat(8)4
Avg EPS beat(8)141.87%
EPS beat(12)5
Avg EPS beat(12)92.1%
EPS beat(16)9
Avg EPS beat(16)74.97%
Revenue beat(2)2
Avg Revenue beat(2)12.17%
Min Revenue beat(2)11.49%
Max Revenue beat(2)12.84%
Revenue beat(4)3
Avg Revenue beat(4)6.23%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)12.84%
Revenue beat(8)6
Avg Revenue beat(8)5.83%
Revenue beat(12)9
Avg Revenue beat(12)5.12%
Revenue beat(16)11
Avg Revenue beat(16)4.39%
PT rev (1m)26.23%
PT rev (3m)65.59%
EPS NQ rev (1m)5.02%
EPS NQ rev (3m)-41.76%
EPS NY rev (1m)0.13%
EPS NY rev (3m)-1.2%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)-2.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 35.5
Fwd PE 37.33
P/S 1.18
P/FCF N/A
P/OCF N/A
P/B 2.12
P/tB 2.29
EV/EBITDA 20.29
EPS(TTM)1.17
EY2.82%
EPS(NY)1.11
Fwd EY2.68%
FCF(TTM)-8.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS35.27
BVpS19.63
TBVpS18.15
PEG (NY)N/A
PEG (5Y)10.23
Profitability
Industry RankSector Rank
ROA 1.44%
ROE 5.99%
ROCE 2.74%
ROIC 2.16%
ROICexc 2.21%
ROICexgc 2.27%
OM 5.11%
PM (TTM) 3.33%
GM 14.48%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 8.56
Cap/Depr 425.09%
Cap/Sales 22.67%
Interest Coverage 0.88
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.54
Altman-Z 1.25
F-Score5
WACC11.29%
ROIC/WACC0.19
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.33%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%166.67%
EPS Next Y-24.12%
EPS Next 2Y4.45%
EPS Next 3Y16.47%
EPS Next 5Y20.21%
Revenue 1Y (TTM)22.86%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%7.83%
Revenue Next Year8.53%
Revenue Next 2Y8.81%
Revenue Next 3Y9.6%
Revenue Next 5Y8.88%
EBIT growth 1Y9.47%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year93.5%
EBIT Next 3Y40.09%
EBIT Next 5Y29.36%
FCF growth 1Y18.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.79%
OCF growth 3YN/A
OCF growth 5YN/A